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Secondary analyses of large datasets provide a mecha-
nism for researchers to address high impact questions
that would otherwise be prohibitively expensive and
time-consuming to study. This paper presents a guide
to assist investigators interested in conducting second-
ary data analysis, including advice on the process of
successful secondary data analysis as well as a brief
summary of high-value datasets and online resources
for researchers, including the SGIM dataset compendium
(www.sgim.org/go/datasets). The same basic research
principles that apply to primary data analysis apply to
secondary data analysis, including the development of a
clear and clinically relevant research question, study
sample, appropriate measures, and a thoughtful analytic
approach. A real-world case description illustrates key
steps: (1) define your research topic and question; (2)
select a dataset; (3) get to know your dataset; and (4)
structure your analysis and presentation of findings in a
way that is clinically meaningful. Secondary dataset
analysis is a well-established methodology. Secondary
analysis is particularly valuable for junior investigators,
who have limited time and resources to demonstrate
expertise and productivity.
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INTRODUCTION
Secondary data analysis is analysis of data that was collected
by someone else for another primary purpose. Increasingly,
generalist researchers start their careers conducting analyses
of existing datasets, and some continue to make this the focus
of their career. Using secondary data enables one to conduct
studies of high-impact research questions with dramatically
less time and resources than required for most studies involving
primary data collection. For fellows and junior faculty who need
to demonstrate productivity by completing and publishing
research in a timely manner, secondary data analysis can be a
key foundation to successfully starting a research career.
Successful completion demonstrates content and methodologi-
calexpertise,andmay yieldusefuldataforfuturegrants.Despite
these attributes, conducting high quality secondary data re-
search requires a distinct skill set and substantial effort.
However,fewframeworksareavailabletoguidenewinvestigators
as they conduct secondary data analysies.
1–3
In this article we describe key principles and skills needed to
conduct successful analysis of secondary data and provide a
brief description of high-value datasets and online resources.
The primary target audience of the article is investigators with
an interest but limited prior experience in secondary data
analysis, as well as mentors of these investigators, who may
find this article a useful reference and teaching tool. While we
focus on analysis of large, publicly available datasets, many of
the concepts we cover are applicable to secondary analysis of
proprietary datasets. Datasets we feature in this manuscript
encompass a wide range of measures, and thus can be useful to
evaluatenotonlyonediseaseinisolation,butalsoitsintersection
with other clinical, demographic, and psychosocial characteris-
tics of patients.
REASONS TO CONDUCT OR TO AVOID
A SECONDARY DATA ANALYSIS
Many worthwhile studies simply cannot be done in a
reasonable timeframe and cost with primary data collection.
For example, if you wanted to examine racial and ethnic
differences in health services utilization over the last 10 years
of life, you could enroll a diverse cohort of subjects with
chronic illness and wait a decade (or longer) for them to die, or
you could find a dataset that includes a diverse sample of
decedents. Even for less dramatic examples, primary data
collection can be difficult without incurring substantial costs,
including time and money—scarce resources for junior
researchers in particular. Secondary datasets, in contrast,
can provide access to large sample sizes, relevant measures,
and longitudinal data, allowing junior investigators to formu-
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920late a generalizable answer to a high impact question. For
those interested in conducting primary data collection,
beginning with a secondary data analysis may provide a “bird’s
eye view” of epidemiologic trends that future primary data
studies examine in greater detail.
Secondary data analyses, however, have disadvantages that
are important to consider. In a study focused on primary data,
you can tightly control the desired study population, specify
the exact measures that you would like to assess, and examine
causal relationships (e.g., through a randomized controlled
design). In secondary data analyses, the study population and
measures collected are often not exactly what you might have
chosen to collect, and the observational nature of most
secondary data makes it difficult to assess causality (although
some quasi-experimental methods, such as instrumental
variable or regression discontinuity analysis, can partially
address this issue). While not unique to secondary data
analysis, another disadvantage to publicly available datasets
is the potential to be “scooped,” meaning that someone else
publishes a similar study from the same data set before you
do. On the other hand, intentional replication of a study in a
different dataset can be important in that it either supports or
refutes the generalizability of the original findings. If you do
find that someone has published the same study using the
same dataset, try to find a unique angle to your study that
builds on their findings.
STEPS TO CONDUCTING A SUCCESSFUL
SECONDARY DATA ANALYSIS
The same basic research principles that apply to studies using
primary data apply to secondary data analysis, including the
development of a clear research question, study sample,
appropriate measures, and a thoughtful analytic approach.
For purposes of secondary data analysis, these principles can
be conceived as a series of four key steps, described in Table 1
and the sections below. Table 2 provides a glossary of terms
used in secondary analysis including dataset types and
common sampling terminology.
Define your Research Topic and Question
Case. A fellow in general medicine has a strong interest in
studying palliative and end-of-life care. Building on his interest
in racial and ethnic disparities, he wants to examine
disparities in use of health services at the end of life. He is
leaning toward conducting a secondary data analysis and is
not sure if he should begin with a more focused research
question or a search for a dataset.
Investigators new to secondary data research are frequently
challenged by the question “which comes first, the question or
the dataset?” In general, we advocate that researchers begin by
defining their research topic or question. A good question is
essential—an uninteresting study with a huge sample size or
extensively validated measures is still uninteresting. The
answer to a research question should have implications for
patient care or public policy. Imagine the possible findings and
ask the dreaded question: "so what?" If possible, select a
question that will be interesting regardless of the direction of
the findings: positive or negative. Also, determine a target
audience who would find your work interesting and useful.
Itisoftenusefultostartwithathoroughliteraturereviewofthe
question or topic of interest. This effort both avoids duplicating
others’workanddevelopswaystobuildupontheliterature.Once
the question is established, identify datasets that are the best fit,
in terms of the patient population, sample size, and measures of
Table 1. A Practical Approach to Successful Research with Large Datasets
Steps Practical advice
(1) Define your research topic and question (1) Start with a thorough literature review
(2) Ensure that the research question has clinical or policy relevance and is based on sound a
priori reasoning. A good question is what makes a study good, not a large sample size
(3) Be flexible to adapt your question to the strengths and limitations of the potential datasets
(2) Select a dataset (1) Use a resource such as the Society of General Internal Medicine’s Online
Compendium (www.sgim.org/go/datasets) (Table 3)
(2) To increase the novelty of your work, consider selecting a dataset that has not been
widely used in your field or link datasets together to gain a fresh perspective
(3) Factor in complexity of the dataset
(4) Factor in dataset cost and time to acquire the actual dataset
(5) Consider selecting a dataset your mentor has used previously
(3) Get to know your dataset (1) Learn the answers to the following questions:
￿Why does the database exist?
￿Who reports the data?
￿What are the incentives for accurate reporting?
￿How are the data audited, if at all?
￿Can you link your dataset to other large datasets?
(2) Read everything you can about the database
(3) Check to see if your measures have been validated against other sources
(4) Get a close feel for the data by analyzing it yourself or closely reviewing outputs if someone else
is doing the programming
(4) Structure your analysis and presentation
of findings in a way that is clinically meaningful
(1) Think carefully about the clinical implications of your findings
(2) Be cautious when interpreting statistical significance (i.e., p-values). Large sample sizes can
yield associations that are highly statistically significant but not clinically meaningful
(3) Consult with a statistician for complex datasets and analyses
(4) Think carefully about how you portray the data. A nice figure sometimes tells the story better
than rows of data
921 Smith et al.: Research with Secondary Data JGIMthe variables of interest (including predictors, outcomes, and
potential confounders). Once a candidate dataset has been
identified, we recommend being flexible and adapting the
research question to the strengths and limitations of the
dataset, as long as the question remains interesting and specific
andthemethodstoansweritarescientificallysound.Becreative.
Some measures of interest may not have been ascertained
directly, but data may be available to construct a suitable proxy.
In some cases, you may find a dataset that initially looked
promising lacks the necessary data (or data quality) to answer
research questions in your area of interest reliably. In that case,
you should be prepared to search for an alternative dataset.
A specific research question is essential to good research.
However, many researchers have a general area of interest but
find it difficult to identify specific research questions without
knowing the specific data available. In that case, combing
research documentation for unexamined yet interesting
measures in your area of interest can be fruitful. Beginning
with the dataset and no focused area of interest may lead to data
dredging—simply creating cross tabulations of unexplored
variables in search of significant associations is bad science. Yet,
in our experience, many good studies have resulted from a
researcher with a general topic area of interest finding a
clinically meaningful yet underutilized measure and having the
insight to frame a research question that uses that measure to
answer a novel and clinically compelling question (see references
for examples).
4–8 Dr. Warren Browner once exhorted, “just
because you were not smart enough to think of a research
question in advance doesn’tm e a ni t ’sn o ti m p o r t a n t ! ” [quote
used with permission].
Select a Dataset
Case Continued. After a review of available datasets that fit his
topic area of interest, the fellow decides to use data from the
Surveillance Epidemiology and End Results Program linked to
Medicare claims (SEER-Medicare).
The range and intricacy of large datasets can be daunting to
a junior researcher. Fortunately, several online compendia are
available to guide researchers (Table 3), including one recently
developed by this manuscript’s authors for the Society of
General Internal Medicine (SGIM) (www.sgim.org/go/
datasets). The SGIM Research Dataset Compendium was
developed and is maintained by members of the SGIM
research committee. SGIM Compendium developers
consulted with experts to identify and profile high-value
datasets for generalist researchers. The Compendium
includes a description of and links to over 40 high-value
datasets used for health services, clinical epidemiology, and
medical education research. The SGIM Compendium provides
Table 2. Glossary of Terms Used in Secondary Dataset Analysis Research
Term Meaning
Types of datasets
(not mutually exclusive)
Administrative or claims data Datasets generated from reimbursement claims, such as ICD-9 codes used to bill for clinical encounters, or
discharge data such as discharge diagnoses
Longitudinal data Datasets that measure factors of interest within the same subjects over time
Clinical registries Datasets generated from registries of specific clinical conditions, such as regional cancer registries used to create
the Surveillance Epidemiology and End Results Program (SEER) dataset
Population-based survey A target population is available and well-defined, and a systematic approach is used to select members
of that population to take part in the study. For example, SEER is a population-based survey because it aims
to include data on all individuals with cancer cared for in the included regions
Nationally representative survey Survey sample that is designed to be representative of the target population on a national level. Often uses a
complex sampling scheme. The Health and Retirement Study (HRS), for example, is nationally representative
of community-dwelling adults over age 50
Panel survey A longitudinal survey in which data are collected in the same panel of subjects over time. As one panel is at the
middle or end of its participation, a panel of new participants is enrolled. In the Medical Expenditures Panel
Survey (MEPS), for example, individuals in the same household are surveyed several times over the course
of 2 years
Statistical sampling terms
Clustering Even simple random samples can be prohibitively expensive for practical reasons such as geographic distance
between selected subjects. Identifying subjects within defined clusters, such as geographic regions or subjects
treated by the same physicians, reduces cost and improves the feasibility of the study but may decrease the
precision of the estimated variance (e.g., wider confidence intervals)
Complex survey design A survey design that is not a simple random selection of subjects. Surveys that incorporate stratification,
clustering and oversampling (with patient weights) are examples of complex data. Statistical software is
available that can account for complex survey designs and is often needed to generate accurate findings
Oversampling Intentionally sampling a greater proportion of a subgroup, increasing the precision of estimates for that
subgroup. For example, in the HRS, African-Americans, Latinos, and residents of Florida are oversampled
(see also survey weights)
Stratification In stratification, the target population is divided into relatively homogeneous groups, and a pre-specified
number of subjects is sampled from within each stratum. For example, in the National Ambulatory Medical
Care Survey physicians are divided by specialty within each geographic area targeted for the survey, and a
certain number of each type of physician is then identified to participate and provide data about their patients
Survey weights Weights are used to account for the unequal probability of subject selection due to purposeful over- or
under-sampling of certain types of subjects and non-response bias. The survey weight is the inverse probability
of being selected. By applying survey weights, the effects of over- and under-sampling of certain types of patients
can be corrected such that the data are representative of the entire target population
922 Smith et al.: Research with Secondary Data JGIMdetailed information of use in selecting a dataset, including
sample sizes and characteristics, available measures and how
data was measured, comments from expert users, links to the
dataset, and example publications (see Box for example). A
selection of datasets from this Compendium is listed in
Table 4. SGIM members can request a one-time telephone
consultation with an expert user of a large dataset (see details
on the Compendium website).
Dataset complexity, cost, and time to acquire the data and
obtain institutional review board (IRB) approval are critical
considerations for junior researchers, who are new to second-
ary analysis, have few financial resources, and limited time to
demonstrate productivity. Table 4 illustrates the complexity
and cost of large datasets across a range of high value datasets
used by generalist researchers. Dataset complexity increases
by number of subjects, file structure (e.g., single versus
multiple records per individual), and complexity of the survey
design. Many publicly available datasets are free, and others
can cost tens of thousands of dollars to obtain. Time to acquire
the datasets and obtain IRB board approval vary. Some
datasets can be downloaded from the web, others require
multiple layers of permission and security, and in some cases
data must be analyzed in a central data processing center. If
the project requires linking new data to an existing database,
this linkage will add to the time needed to complete the project
and probably require enhanced data security. One advantage
Box. Example excerpted from the Society of General Internal Medicine (SGIM) Online Compendium: 
National Ambulatory Medical Care Survey & National Hospital Ambulatory Care Survey 
Key web links    
Home Page 
www.cdc.gov/nchs/about/major/ahcd/ahcd1.htm
NAMCS Survey Instruments 
http://www.cdc.gov/nchs/about/major/ahcd/surinst.htm#Survey%20Instrument%20NAMCS
NHAMCS Survey Instruments 
http://www.cdc.gov/nchs/about/major/ahcd/surinst.htm#Survey%20Instrument%20NHAMCS
Dataset Summary 
NAMCS and NHAMCS comprise nationally representative surveys of outpatient and emergency department 
visits in the United States from 1973 through the present.  Each year, physicians in community-based office 
practices, hospital-associated office practices, and emergency rooms are asked to complete forms about 
outpatient visits by individual patients.  Altogether, both surveys collect data on approximately 80,000 patient 
visits per year.  The surveys are clustered and weighted in such a way that results from the research databases 
can be easily extrapolated to produce nationally representative estimates.  Data is available for downloading off 
the web at no cost.  All records are completely de-identified for protected health information.  Participating 
physicians (and their patients) vary from year to year, so there is no longitudinal followup, although the serial 
cross-sectional nature of the survey allows for tracking of trends over time. 
Expert comments    
NAMCS and NHAMCS are wonderful resources.  The data are easy to access and use, and the website 
provides highly useful documentation about how to program Stata, SAS, and SPSS to adjust for survey 
clustering, stratification, and weighting.   These datasets are ideally suited to evaluate practices that occur at 
individual office visits; for example, the prevalence of reasons for office visits, characteristics of patients 
receiving care (and clinicians providing care) in different outpatient settings, interventions offered at individual 
visits (such as medication prescribing, diagnostic test-ordering), and so forth.  Both surveys have also been 
used to evaluate chronic diseases and their treatments, for example, evaluating chronic NSAID or statin use in 
older patients.  However, both surveys are less ideally suited to evaluating the prevalence and treatment of 
chronic diseases, since the main focus of the survey is on the content of the individual visit and chronic 
diseases or medications may be more likely to not be recorded on the survey.  It is also important to note that 
the majority of surveys are filled out by office staff and NHCS representatives based on clinic notes, rather than 
the physicians themselves.  NAMCS was validated against direct observation
32 and found to be most accurate 
for procedures and examinations; behavioral counseling was underreported and visit duration overestimated 
compared with direct observation.
923 Smith et al.: Research with Secondary Data JGIMof most secondary studies using publicly available datasets is
the rapid time to IRB approval. Many publicly available large
datasets contain de-identified data and are therefore eligible
for expedited review or exempt status. If you can download the
dataset from the web, it is probably exempt, but your local IRB
must make this determination.
Linking datasets can be a powerful method for examining
an issue by providing multiple perspectives of patient
experience. Many datasets, including SEER, for example,
can be linked to the Area Resource File to examine regional
variation in practice patterns. However, linking datasets
together increases the complexity and cost of data manage-
ment. A new researcher might consider first conducting a
study only on the initial database, and then conducting
their next study using the linked database. For some new
investigators, this approach can progressively advance
Table 3. Online Compendia of Secondary Datasets
Compendium Web address Description
Society of General Internal Medicine
(SGIM) Research Dataset
Compendium
www.sgim.org/go/datasets Designed to assist investigators conducting
research on existing datasets, with a particular
emphasis on health services research, clinical
epidemiology, and research on medical
education. Includes information on strengths
and weaknesses of datasets and the insights of
experienced users about making best use
of the data
National Information Center on Health
Services Research and Health Care
Technology (NICHSR)
http://www.nlm.nih.gov/nichsr/index.html This group of sites provides links to a wide
variety of data tools and statistics, including
research datasets, data repositories, health
statistics, survey instruments, and more. It is
sponsored by the National Library of Medicine
Inter-University Consortium for Political
and Social Research (ICPSR)
https://www.icpsr.umich.edu World’s largest archive of digital social science
data, including many datasets with extensive
information on health and health care. ICPSR
includes many sub-archives on specific topic
areas, including minority health, international
data, substance abuse, and mental
health, and more
Partners in Information Access for the
Public Health Workforce
http://phpartners.org/health_stats.html Provides links to a variety of national, state,
and local health and public health datasets.
Also provides links to sites providing a wide
variety of health statistics, information on
health information technology and standards,
and other resources. Sponsored by a
collaboration of US government agencies,
public health organizations, and health
sciences libraries
Canadian Research Data Centres http://www.statcan.gc.ca/rdc-cdr/index-eng.htm Links to datasets available for analysis through
Canada’s Research Data Centres (RDC)
program
Directory of Health and Human
Services Data Resources
(US Dept. of Health and
Human Services)
http://aspe.hhs.gov/datacncl/DataDir/index.shtml This site provides brief information and links
to almost all datasets from National Institutes
of Health (NIH), Centers for Disease Control and
Prevention (CDC), Centers for Medicare and
Medicaid Services (CMS), Agency for
Healthcare Research and Quality (AHRQ), Food
and Drug Administration (FDA), and other
agencies of the US Department of Health
and Human Services
National Center for Health
Statistics (NCHS)
http://www.cdc.gov/nchs/index.htm This site links to a variety of datasets from the
National Center for Health Statistics, several
of which are profiled in Table 4. These datasets
are available for downloading at no cost
Medicare Research Data Assistance
Center (RESDAC); and Centers
for Medicare and Medicaid
Services (CMS) Research,
Statistics, Data & Systems
www.resdac.umn.edu/Available_CMS_Data.asp These sites link to a variety of datasets from the
Centers for Medicare and Medicaid Services
(CMS)
Veterans Affairs (VA) data www.virec.research.va.gov/index.htm A series of datasets using administrative and
computerized clinical data to describe care
provided in the VA health care system,
including information on outpatient visits,
pharmacy data, inpatient data, cost data,
and more. With some exceptions, use is
generally restricted to researchers with VA
affiliations (this can include a co-investigator
with a VA affiliation)
924 Smith et al.: Research with Secondary Data JGIMT
a
b
l
e
4
.
E
x
a
m
p
l
e
s
o
f
H
i
g
h
V
a
l
u
e
D
a
t
a
s
e
t
s
C
o
s
t
,
a
v
a
i
l
a
b
i
l
i
t
y
,
a
n
d
c
o
m
p
l
e
x
i
t
y
D
a
t
a
s
e
t
D
e
s
c
r
i
p
t
i
o
n
S
a
m
p
l
e
p
u
b
l
i
c
a
t
i
o
n
s
F
r
e
e
.
R
e
a
d
i
l
y
a
v
a
i
l
a
b
l
e
.
P
o
p
u
l
a
t
i
o
n
-
b
a
s
e
d
s
u
r
v
e
y
w
i
t
h
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
d
e
s
i
g
n
.
D
o
e
s
n
o
t
r
e
q
u
i
r
e
s
p
e
c
i
a
l
s
t
a
t
i
s
t
i
c
a
l
t
e
c
h
n
i
q
u
e
s
t
o
a
d
d
r
e
s
s
c
o
m
p
l
e
x
s
a
m
p
l
i
n
g
S
u
r
v
e
i
l
l
a
n
c
e
,
E
p
i
d
e
m
i
o
l
o
g
y
a
n
d
E
n
d
R
e
s
u
l
t
s
P
r
o
g
r
a
m
(
S
E
E
R
)
h
t
t
p
:
/
/
w
w
w
.
s
e
e
r
.
c
a
n
c
e
r
.
g
o
v
/
P
o
p
u
l
a
t
i
o
n
-
b
a
s
e
d
m
u
l
t
i
-
r
e
g
i
o
n
a
l
c
a
n
c
e
r
r
e
g
i
s
t
r
y
d
a
t
a
b
a
s
e
.
S
E
E
R
d
a
t
a
a
r
e
u
p
d
a
t
e
d
a
n
n
u
a
l
l
y
.
C
a
n
b
e
l
i
n
k
e
d
t
o
M
e
d
i
c
a
r
e
c
l
a
i
m
s
a
n
d
f
i
l
e
s
(
s
e
e
M
e
d
i
c
a
r
e
b
e
l
o
w
)
T
r
e
n
d
s
i
n
b
r
e
a
s
t
-
c
o
n
s
e
r
v
i
n
g
s
u
r
g
e
r
y
a
m
o
n
g
A
s
i
a
n
A
m
e
r
i
c
a
n
s
a
n
d
P
a
c
i
f
i
c
I
s
l
a
n
d
e
r
s
,
1
9
9
2
–
2
0
0
0
1
2
T
r
e
a
t
m
e
n
t
a
n
d
o
u
t
c
o
m
e
s
o
f
g
a
s
t
r
i
c
c
a
n
c
e
r
a
m
o
n
g
U
S
-
b
o
r
n
a
n
d
f
o
r
e
i
g
n
-
b
o
r
n
A
s
i
a
n
s
a
n
d
P
a
c
i
f
i
c
I
s
l
a
n
d
e
r
s
1
3
F
r
e
e
.
R
e
a
d
i
l
y
a
v
a
i
l
a
b
l
e
.
R
e
q
u
i
r
e
s
s
t
a
t
i
s
t
i
c
a
l
c
o
n
s
i
d
e
r
a
t
i
o
n
s
t
o
a
c
c
o
u
n
t
f
o
r
c
o
m
p
l
e
x
s
a
m
p
l
i
n
g
d
e
s
i
g
n
a
n
d
u
s
e
o
f
s
u
r
v
e
y
w
e
i
g
h
t
s
N
a
t
i
o
n
a
l
A
m
b
u
l
a
t
o
r
y
M
e
d
i
c
a
l
C
a
r
e
S
u
r
v
e
y
(
N
A
M
C
S
)
&
N
a
t
i
o
n
a
l
H
o
s
p
i
t
a
l
A
m
b
u
l
a
t
o
r
y
C
a
r
e
S
u
r
v
e
y
(
N
H
A
M
C
S
)
h
t
t
p
:
/
/
w
w
w
.
c
d
c
.
g
o
v
/
n
c
h
s
/
a
h
c
d
.
h
t
m
N
a
t
i
o
n
a
l
l
y
-
r
e
p
r
e
s
e
n
t
a
t
i
v
e
s
e
r
i
a
l
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
s
u
r
v
e
y
s
o
f
o
u
t
p
a
t
i
e
n
t
a
n
d
e
m
e
r
g
e
n
c
y
d
e
p
a
r
t
m
e
n
t
v
i
s
i
t
s
.
C
a
n
c
o
m
b
i
n
e
s
u
r
v
e
y
y
e
a
r
s
t
o
i
n
c
r
e
a
s
e
s
a
m
p
l
e
s
i
z
e
s
(
e
.
g
.
,
f
o
r
u
n
c
o
m
m
o
n
c
o
n
d
i
t
i
o
n
s
)
o
r
e
v
a
l
u
a
t
e
t
e
m
p
o
r
a
l
t
r
e
n
d
s
.
P
r
o
v
i
d
e
s
n
a
t
i
o
n
a
l
e
s
t
i
m
a
t
e
s
P
r
e
v
e
n
t
i
v
e
h
e
a
l
t
h
e
x
a
m
i
n
a
t
i
o
n
s
a
n
d
p
r
e
v
e
n
t
i
v
e
g
y
n
e
c
o
l
o
g
i
c
a
l
e
x
a
m
i
n
a
t
i
o
n
s
i
n
t
h
e
U
S
1
4
T
h
e
N
A
M
C
S
a
n
d
N
H
A
M
C
S
a
r
e
c
o
n
d
u
c
t
e
d
a
n
n
u
a
l
l
y
.
D
o
n
o
t
l
i
n
k
t
o
o
t
h
e
r
d
a
t
a
s
e
t
s
P
r
i
m
a
r
y
c
a
r
e
p
h
y
s
i
c
i
a
n
o
f
f
i
c
e
v
i
s
i
t
s
f
o
r
d
e
p
r
e
s
s
i
o
n
b
y
o
l
d
e
r
A
m
e
r
i
c
a
n
s
1
5
N
a
t
i
o
n
a
l
H
e
a
l
t
h
I
n
t
e
r
v
i
e
w
S
u
r
v
e
y
(
N
H
I
S
)
h
t
t
p
:
/
/
w
w
w
.
c
d
c
.
g
o
v
/
n
c
h
s
/
n
h
i
s
.
h
t
m
N
a
t
i
o
n
a
l
l
y
-
r
e
p
r
e
s
e
n
t
a
t
i
v
e
s
e
r
i
a
l
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
s
u
r
v
e
y
o
f
i
n
d
i
v
i
d
u
a
l
s
a
n
d
f
a
m
i
l
i
e
s
i
n
c
l
u
d
i
n
g
i
n
f
o
r
m
a
t
i
o
n
o
n
h
e
a
l
t
h
s
t
a
t
u
s
,
i
n
j
u
r
i
e
s
,
h
e
a
l
t
h
i
n
s
u
r
a
n
c
e
,
a
c
c
e
s
s
a
n
d
u
t
i
l
i
z
a
t
i
o
n
i
n
f
o
r
m
a
t
i
o
n
.
T
h
e
N
H
I
S
i
s
c
o
n
d
u
c
t
e
d
a
n
n
u
a
l
l
y
.
C
a
n
c
o
m
b
i
n
e
s
u
r
v
e
y
y
e
a
r
s
t
o
l
o
o
k
a
t
r
a
r
e
c
o
n
d
i
t
i
o
n
s
P
s
y
c
h
o
l
o
g
i
c
a
l
d
i
s
t
r
e
s
s
i
n
l
o
n
g
-
t
e
r
m
s
u
r
v
i
v
o
r
s
o
f
a
d
u
l
t
-
o
n
s
e
t
c
a
n
c
e
r
:
r
e
s
u
l
t
s
f
r
o
m
a
n
a
t
i
o
n
a
l
s
u
r
v
e
y
1
6
C
a
n
b
e
l
i
n
k
e
d
t
o
N
a
t
i
o
n
a
l
C
e
n
t
e
r
f
o
r
H
e
a
l
t
h
S
t
a
t
i
s
t
i
c
s
M
o
r
t
a
l
i
t
y
D
a
t
a
;
M
e
d
i
c
a
r
e
e
n
r
o
l
l
m
e
n
t
a
n
d
c
l
a
i
m
s
d
a
t
a
;
S
o
c
i
a
l
S
e
c
u
r
i
t
y
B
e
n
e
f
i
t
H
i
s
t
o
r
y
D
a
t
a
;
M
e
d
i
c
a
l
E
x
p
e
n
d
i
t
u
r
e
P
a
n
e
l
S
u
r
v
e
y
(
M
E
P
S
)
d
a
t
a
;
a
n
d
N
a
t
i
o
n
a
l
I
m
m
u
n
i
z
a
t
i
o
n
P
r
o
v
i
d
e
r
R
e
c
o
r
d
s
C
h
e
c
k
S
u
r
v
e
y
(
N
I
P
R
C
S
)
d
a
t
a
f
r
o
m
1
9
9
7
–
1
9
9
9
D
i
a
b
e
t
e
s
a
n
d
C
a
r
d
i
o
v
a
s
c
u
l
a
r
D
i
s
e
a
s
e
a
m
o
n
g
A
s
i
a
n
I
n
d
i
a
n
s
i
n
t
h
e
U
S
1
7
B
e
h
a
v
i
o
r
a
l
R
i
s
k
F
a
c
t
o
r
S
u
r
v
e
i
l
l
a
n
c
e
S
y
s
t
e
m
(
B
R
F
S
S
)
h
t
t
p
:
/
/
w
w
w
.
c
d
c
.
g
o
v
/
b
r
f
s
s
/
S
e
r
i
a
l
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
n
a
t
i
o
n
a
l
l
y
-
r
e
p
r
e
s
e
n
t
a
t
i
v
e
s
u
r
v
e
y
o
f
h
e
a
l
t
h
r
i
s
k
b
e
h
a
v
i
o
r
s
,
p
r
e
v
e
n
t
a
t
i
v
e
h
e
a
l
t
h
p
r
a
c
t
i
c
e
s
,
a
n
d
h
e
a
l
t
h
c
a
r
e
a
c
c
e
s
s
.
P
r
o
v
i
d
e
s
n
a
t
i
o
n
a
l
a
n
d
s
t
a
t
e
e
s
t
i
m
a
t
e
s
.
S
i
n
c
e
2
0
0
2
,
t
h
e
S
e
l
e
c
t
e
d
M
e
t
r
o
p
o
l
i
t
a
n
/
M
i
c
r
o
p
o
l
i
t
a
n
A
r
e
a
R
i
s
k
T
r
e
n
d
s
(
S
M
A
R
T
)
p
r
o
j
e
c
t
h
a
s
a
l
s
o
u
s
e
d
B
R
F
S
S
d
a
t
a
t
o
i
d
e
n
t
i
f
y
t
r
e
n
d
s
i
n
s
e
l
e
c
t
e
d
m
e
t
r
o
p
o
l
i
t
a
n
a
n
d
m
i
c
r
o
p
o
l
i
t
a
n
s
t
a
t
i
s
t
i
c
a
l
a
r
e
a
s
(
M
M
S
A
s
)
w
i
t
h
5
0
0
o
r
m
o
r
e
r
e
s
p
o
n
d
e
n
t
s
.
B
R
F
S
S
d
a
t
a
a
r
e
c
o
l
l
e
c
t
e
d
m
o
n
t
h
l
y
.
D
o
e
s
n
o
t
l
i
n
k
t
o
o
t
h
e
r
d
a
t
a
s
e
t
s
P
e
r
c
e
i
v
e
d
d
i
s
c
r
i
m
i
n
a
t
i
o
n
i
n
h
e
a
l
t
h
c
a
r
e
a
n
d
u
s
e
o
f
p
r
e
v
e
n
t
i
v
e
h
e
a
l
t
h
s
e
r
v
i
c
e
s
1
8
U
s
e
o
f
r
e
c
o
m
m
e
n
d
e
d
a
m
b
u
l
a
t
o
r
y
c
a
r
e
s
e
r
v
i
c
e
s
:
i
s
t
h
e
V
e
t
e
r
a
n
s
A
f
f
a
i
r
s
q
u
a
l
i
t
y
g
a
p
n
a
r
r
o
w
i
n
g
?
1
9
F
r
e
e
o
r
m
i
n
i
m
a
l
c
o
s
t
.
R
e
a
d
i
l
y
a
v
a
i
l
a
b
l
e
.
C
a
n
d
o
m
o
r
e
c
o
m
p
l
e
x
s
t
u
d
i
e
s
b
y
c
o
m
b
i
n
i
n
g
d
a
t
a
f
r
o
m
m
u
l
t
i
p
l
e
w
a
v
e
s
a
n
d
/
o
r
r
e
c
o
r
d
s
.
A
c
c
o
u
n
t
i
n
g
f
o
r
c
o
m
p
l
e
x
s
a
m
p
l
i
n
g
d
e
s
i
g
n
a
n
d
u
s
e
o
f
s
u
r
v
e
y
w
e
i
g
h
t
s
c
a
n
b
e
m
o
r
e
c
o
m
p
l
e
x
w
h
e
n
u
s
i
n
g
m
u
l
t
i
p
l
e
w
a
v
e
s
—
s
e
e
k
s
u
p
p
o
r
t
f
r
o
m
a
s
t
a
t
i
s
t
i
c
i
a
n
.
O
r
c
a
n
r
e
s
t
r
i
c
t
s
a
m
p
l
e
t
o
s
i
n
g
l
e
w
a
v
e
s
f
o
r
e
a
s
e
o
f
u
s
e
N
a
t
i
o
n
w
i
d
e
I
n
p
a
t
i
e
n
t
S
a
m
p
l
e
(
N
I
S
)
h
t
t
p
:
/
/
w
w
w
.
h
c
u
p
-
u
s
.
a
h
r
q
.
g
o
v
/
d
a
t
a
b
a
s
e
s
.
j
s
p
T
h
e
l
a
r
g
e
s
t
U
S
d
a
t
a
b
a
s
e
o
f
i
n
p
a
t
i
e
n
t
h
o
s
p
i
t
a
l
s
t
a
y
s
t
h
a
t
i
n
c
o
r
p
o
r
a
t
e
s
d
a
t
a
f
r
o
m
a
l
l
p
a
y
e
r
s
,
c
o
n
t
a
i
n
i
n
g
d
a
t
a
f
r
o
m
a
p
p
r
o
x
i
m
a
t
e
l
y
2
0
%
o
f
U
S
c
o
m
m
u
n
i
t
y
h
o
s
p
i
t
a
l
s
.
S
a
m
p
l
i
n
g
f
r
a
m
e
i
n
c
l
u
d
e
s
a
p
p
r
o
x
i
m
a
t
e
l
y
9
0
%
o
f
d
i
s
c
h
a
r
g
e
s
f
r
o
m
U
S
h
o
s
p
i
t
a
l
s
F
a
c
t
o
r
s
a
s
s
o
c
i
a
t
e
d
w
i
t
h
p
a
t
i
e
n
t
s
w
h
o
l
e
a
v
e
a
c
u
t
e
-
c
a
r
e
h
o
s
p
i
t
a
l
s
a
g
a
i
n
s
t
m
e
d
i
c
a
l
a
d
v
i
c
e
2
0
N
I
S
d
a
t
a
i
s
c
o
l
l
e
c
t
e
d
a
n
n
u
a
l
l
y
.
F
o
r
m
o
s
t
s
t
a
t
e
s
,
t
h
e
N
I
S
i
n
c
l
u
d
e
s
h
o
s
p
i
t
a
l
i
d
e
n
t
i
f
i
e
r
s
t
h
a
t
p
e
r
m
i
t
l
i
n
k
a
g
e
s
t
o
t
h
e
A
m
e
r
i
c
a
n
H
o
s
p
i
t
a
l
A
s
s
o
c
i
a
t
i
o
n
(
A
H
A
)
A
n
n
u
a
l
S
u
r
v
e
y
D
a
t
a
b
a
s
e
a
n
d
c
o
u
n
t
y
i
d
e
n
t
i
f
i
e
r
s
t
h
a
t
p
e
r
m
i
t
l
i
n
k
a
g
e
s
t
o
t
h
e
A
r
e
a
R
e
s
o
u
r
c
e
F
i
l
e
(
A
R
F
)
I
m
p
a
c
t
o
f
h
o
s
p
i
t
a
l
v
o
l
u
m
e
o
n
r
a
c
i
a
l
d
i
s
p
a
r
i
t
i
e
s
i
n
c
a
r
d
i
o
v
a
s
c
u
l
a
r
p
r
o
c
e
d
u
r
e
m
o
r
t
a
l
i
t
y
2
1
N
a
t
i
o
n
a
l
H
e
a
l
t
h
a
n
d
N
u
t
r
i
t
i
o
n
E
x
a
m
i
n
a
t
i
o
n
S
u
r
v
e
y
(
N
H
A
N
E
S
)
h
t
t
p
:
/
/
w
w
w
.
c
d
c
.
g
o
v
/
n
c
h
s
/
n
h
a
n
e
s
.
h
t
m
N
a
t
i
o
n
a
l
l
y
-
r
e
p
r
e
s
e
n
t
a
t
i
v
e
s
e
r
i
e
s
o
f
s
t
u
d
i
e
s
c
o
m
b
i
n
i
n
g
d
a
t
a
f
r
o
m
i
n
t
e
r
v
i
e
w
s
,
p
h
y
s
i
c
a
l
e
x
a
m
i
n
a
t
i
o
n
,
a
n
d
l
a
b
o
r
a
t
o
r
y
t
e
s
t
s
D
e
m
o
g
r
a
p
h
i
c
d
i
f
f
e
r
e
n
c
e
s
a
n
d
t
r
e
n
d
s
o
f
v
i
t
a
m
i
n
D
i
n
s
u
f
f
i
c
i
e
n
c
y
i
n
t
h
e
U
S
p
o
p
u
l
a
t
i
o
n
,
1
9
8
8
-
2
0
0
4
2
2
N
H
A
N
E
S
d
a
t
a
a
r
e
c
o
l
l
e
c
t
e
d
a
n
n
u
a
l
l
y
.
C
a
n
b
e
l
i
n
k
e
d
t
o
N
a
t
i
o
n
a
l
D
e
a
t
h
I
n
d
e
x
(
N
D
I
)
m
o
r
t
a
l
i
t
y
d
a
t
a
;
M
e
d
i
c
a
r
e
e
n
r
o
l
l
m
e
n
t
a
n
d
c
l
a
i
m
s
d
a
t
a
;
S
o
c
i
a
l
S
e
c
u
r
i
t
y
B
e
n
e
f
i
t
H
i
s
t
o
r
y
D
a
t
a
;
a
n
d
M
e
d
i
c
a
l
E
x
p
e
n
d
i
t
u
r
e
P
a
n
e
l
S
u
r
v
e
y
(
M
E
P
S
)
d
a
t
a
;
a
n
d
D
u
a
l
E
n
e
r
g
y
X
-
R
a
y
A
b
s
o
r
p
t
i
o
m
e
t
r
y
(
D
X
A
)
M
u
l
t
i
p
l
e
I
m
p
u
t
a
t
i
o
n
D
a
t
a
F
i
l
e
s
f
r
o
m
1
9
9
9
–
2
0
0
4
A
s
s
o
c
i
a
t
i
o
n
o
f
h
y
p
e
r
t
e
n
s
i
o
n
,
d
i
a
b
e
t
e
s
,
d
y
s
l
i
p
i
d
e
m
i
a
,
a
n
d
m
e
t
a
b
o
l
i
c
s
y
n
d
r
o
m
e
w
i
t
h
o
b
e
s
i
t
y
:
f
i
n
d
i
n
g
s
f
r
o
m
t
h
e
N
a
t
i
o
n
a
l
H
e
a
l
t
h
a
n
d
N
u
t
r
i
t
i
o
n
E
x
a
m
i
n
a
t
i
o
n
S
u
r
v
e
y
,
1
9
9
9
t
o
2
0
0
4
2
3
T
h
e
H
e
a
l
t
h
a
n
d
R
e
t
i
r
e
m
e
n
t
S
t
u
d
y
(
H
R
S
)
h
t
t
p
:
/
/
h
r
s
o
n
l
i
n
e
.
i
s
r
.
u
m
i
c
h
.
e
d
u
/
i
n
d
e
x
.
p
h
p
A
n
a
t
i
o
n
a
l
l
y
-
r
e
p
r
e
s
e
n
t
a
t
i
v
e
l
o
n
g
i
t
u
d
i
n
a
l
s
u
r
v
e
y
o
f
a
d
u
l
t
s
o
l
d
e
r
t
h
a
n
5
0
d
e
s
i
g
n
e
d
t
o
a
s
s
e
s
s
h
e
a
l
t
h
s
t
a
t
u
s
,
e
m
p
l
o
y
m
e
n
t
d
e
c
i
s
i
o
n
s
,
a
n
d
e
c
o
n
o
m
i
c
s
e
c
u
r
i
t
y
d
u
r
i
n
g
r
e
t
i
r
e
m
e
n
t
C
h
r
o
n
i
c
c
o
n
d
i
t
i
o
n
s
a
n
d
m
o
r
t
a
l
i
t
y
a
m
o
n
g
t
h
e
o
l
d
e
s
t
o
l
d
2
4
H
R
S
d
a
t
a
i
s
c
o
l
l
e
c
t
e
d
e
v
e
r
y
2
y
e
a
r
s
.
C
a
n
b
e
l
i
n
k
e
d
t
o
S
o
c
i
a
l
S
e
c
u
r
i
t
y
A
d
m
i
n
i
s
t
r
a
t
i
o
n
d
a
t
a
;
I
n
t
e
r
n
a
l
R
e
v
e
n
u
e
S
e
r
v
i
c
e
d
a
t
a
;
M
e
d
i
c
a
r
e
c
l
a
i
m
s
d
a
t
a
(
s
e
e
M
e
d
i
c
a
r
e
b
e
l
o
w
)
;
a
n
d
M
i
n
i
m
u
m
D
a
t
a
S
e
t
(
M
D
S
)
d
a
t
a
A
d
v
a
n
c
e
d
i
r
e
c
t
e
d
a
n
d
s
u
r
r
o
g
a
t
e
d
e
c
i
s
i
o
n
m
a
k
i
n
g
b
e
f
o
r
e
d
e
a
t
h
2
5
M
e
d
i
c
a
l
E
x
p
e
n
d
i
t
u
r
e
P
a
n
e
l
S
u
r
v
e
y
(
M
E
P
S
)
h
t
t
p
:
/
/
w
w
w
.
m
e
p
s
.
a
h
r
q
.
g
o
v
/
m
e
p
s
w
e
b
/
S
e
r
i
a
l
n
a
t
i
o
n
a
l
l
y
-
r
e
p
r
e
s
e
n
t
a
t
i
v
e
p
a
n
e
l
s
u
r
v
e
y
o
f
i
n
d
i
v
i
d
u
a
l
s
,
f
a
m
i
l
i
e
s
,
h
e
a
l
t
h
c
a
r
e
p
r
o
v
i
d
e
r
s
,
a
n
d
e
m
p
l
o
y
e
r
s
c
o
v
e
r
i
n
g
a
v
a
r
i
e
t
y
o
f
t
o
p
i
c
s
.
M
E
P
S
d
a
t
a
a
r
e
c
o
l
l
e
c
t
e
d
a
n
n
u
a
l
l
y
L
o
s
s
o
f
h
e
a
l
t
h
i
n
s
u
r
a
n
c
e
a
m
o
n
g
n
o
n
-
e
l
d
e
r
l
y
a
d
u
l
t
s
i
n
M
e
d
i
c
a
i
d
2
6
C
a
n
b
e
l
i
n
k
e
d
b
y
r
e
q
u
e
s
t
t
o
t
h
e
A
g
e
n
c
y
f
o
r
H
e
a
l
t
h
c
a
r
e
R
e
s
e
a
r
c
h
a
n
d
Q
u
a
l
i
t
y
t
o
n
u
m
e
r
o
u
s
d
a
t
a
s
e
t
s
i
n
c
l
u
d
i
n
g
t
h
e
N
H
I
S
,
M
e
d
i
c
a
r
e
d
a
t
a
,
a
n
d
S
o
c
i
a
l
S
e
c
u
r
i
t
y
d
a
t
a
I
n
f
l
u
e
n
c
e
o
f
p
a
t
i
e
n
t
-
p
r
o
v
i
d
e
r
c
o
m
m
u
n
i
c
a
t
i
o
n
o
n
c
o
l
o
r
e
c
t
a
l
c
a
n
c
e
r
s
c
r
e
e
n
i
n
g
2
7
(
c
o
n
t
i
n
u
e
d
o
n
n
e
x
t
p
a
g
e
)
925 Smith et al.: Research with Secondary Data JGIMprogramming skills and build confidence while demonstrating
productivity.
Get to Know your Dataset
Case Continued. The fellow’s primary mentor encourages him
to closely examine the accuracy of the primary predictor for his
study—race and ethnicity—as reported in SEER-Medicare.
The fellow has a breakthrough when he finds an entire issue
of the journal Medical Care dedicated to SEER-Medicare,
including a whole chapter on the accuracy of coding of
sociodemographic factors.
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In an analysis of primary data you select the patients to be
studied and choose the study measures. This process gives
you a close familiarity with study subjects, and how and what
data were collected, that is invaluable in assessing the
validity of their measures, the potential bias in measuring
associations between predictors and outcome variables
(internal validity), and the generalizability of their findings to
target populations (external validity). The importance of this
familiarity with the strengths and weaknesses of the dataset
cannot be overemphasized. Secondary data research requires
considerable effort to obtain the same level of familiarity with
the data. Therefore, knowing your data in detail is critical.
Practically, this objective requires scouring online
documentation and technical survey manuals, searching
PubMed for validation studies, and closely reading previous
studies using your dataset, to answer the following types of
questions: Who collected the data, and for what purpose?
How did subjects get into your dataset? How were they
followed? Do your measures capture what you think they
capture?
We strongly recommend taking advantage of help offered
by the dataset managers, typically described on the dataset’s
website. For example, the Research Data Assistance Center
(ResDAC) is a dedicated resource for researchers using data
from the Centers for Medicare and Medicaid Services
(CMS).
Assessing the validity of your measures is one of the central
challenges of large dataset research. For large survey datasets, a
good first step in assessing the validity of your measures is to
read the questions as they were asked in the survey. Some
questions simply have face validity. Others, unfortunately, were
collected in a way that makes the measure meaningless,
problematic, or open to a range of interpretations. These
ambiguities can occur in how the question was asked or in how
t h ed a t aw e r er e c o r d e di n t or e s p o n s ec a t e g o r i e s .
Another essential step is to search the online documentation
and published literature for previous validation studies. A
PubMed search using the dataset name or measure name/type
and the publication type “validation studies” is a good starting
point. The key question for a validity study relates to how and
why the question was asked and data were collected (e.g., self-
report, chart abstraction, physicalmeasurements, billing claims)
in relationship to a gold standard. For example, if you are using
claims data you should recognize that the primary purpose of
those data was not for research, but for reimbursement.
Consequently, claims data are limited by the scope of services
that are reimbursable and the accuracy of coding by clinicians
completing encounter forms for billing or by coders in the claims
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be assessed by asking subjects if they have the condition of
interest, such as self reported diagnosis of hypertension. Self-
reporteddata may beadequate for someresearchquestions (e.g.,
does a diagnosis of hypertension lead people to exercise more?),
but inadequate for others (e.g., the prevalence of
hypertension among people with diabetes). Even measured
data, such as blood pressure, have limitations in that
methods of measurement for a study may differ from
m e t h o d su s e dt od i a g n o s ead i s o r d e ri nt h ec l i n i c i a n ’s
office. In the National Health and Nutrition Examination
Survey, for example, subject’s blood pressure is based on
the average of several measures in a single visit. This
differs from the standard clinical practice of measuring
blood pressure at separate office visits before diagnosing
hypertension. Rarely do available measures capture exactly
what you are trying to study. In our experience measures in
existing datasets are often good enough to answer the
research question, with proper interpretation to account
for what the measures actually assesses and how they
differ from the underlying constructs.
Finally, we suggest paying close attention to the
completeness of measures, and evaluating whether missing
data are random or non-random (the latter might result in
bias, whereas the former is generally acceptable). Statistical
approaches to missing data are beyond the scope of this
paper, and most statisticians can help you address this
problem appropriately. However, pay close attention to “skip
patterns”; some data are missing simply because the survey
item is only asked of a subset for which it applies. For
example, in the Health and Retirement Study the question
about need for assistance with toileting is only asked of
subjects who respond that they have difficulty using the
toilet. If you were unaware of this skip pattern and attempted
to study assistance with toileting, you would be distressed to
find over three-quarters of respondents had missing
responses for this question (because they reported no
difficulty using the toilet).
Fellows and other trainees usually do their own computer
programming. Although this may be daunting, we encourage
this practice so fellows can get a close feel for the data and
become more skilled in statistical analysis. Datasets, however,
range in complexity (Table 4). In our experience, fellows who
have completed introductory training in SAS, STATA, SPSS, or
other similar statistical software have been highly successful
analyzing datasets of moderate complexity without the on-
going assistance of a statistical programmer. However, if you
do have a programmer who will do much of the coding, be
closely involved and review all data cleaning and statistical
output as if you had programmed it yourself. Close attention
can reveal all sorts of patterns, problems, and opportunities
with the data that are obscured by focusing only on the final
outputs prepared by a statistical programmer. Programmers
and statisticians are not clinicians; they will often not
recognize when the values of variables or patterns of
missingness don’t make sense. If estimates seem implausible
or do not match previously published estimates, then the
analytic plan, statistical code, and measures should be
carefully rechecked.
Keep in mind that “the perfect may be the enemy of the
good.” No one expects perfect measures (this is also true for
primary data collection). The closer you are to the data, the
more you see the warts—don’t be discouraged by this. The
measures need to pass the sniff test, in other words have
clinical validity based primarily on judgement that they make
sense clinically or scientifically, but also supported where
possible by validation procedures, reference to auditing
procedures, or in other studies that have independently
validated the measures of interest.
Structure your Analysis and Presentation
of Findings in a Way that Is Clinically Meaningful
Case continued. The fellow finds that Blacks are less likely to
receive chemotherapy in the last 2 weeks of life (Blacks 4%,
Whites 6%, p < 0.001). He debates the meaning of this
statistically significant 2% absolute difference.
Often, the main challenge for investigators who are new to
secondary data analysis is carefully structuring the analysis
and presentation of findings in a way that tells a meaningful
story. Based on what you’ve found, what is the story that you
want your target audience to understand? When appropriate,
it can be useful to conduct carefully planned sensitivity
analysis to evaluate the robustness of your primary findings.
A sensitivity analysis assesses the effect of variation in
assumptions on the outcome of interest. For example, if 10%
of subjects did not answer a “yes” or “no” question, you could
conduct sensitivity analyses to estimate the effects of excluding
missing responses, or categorizing them as all “yes” or all “no.”
Because large datasets may contain multiple measures of
interests, co-variates, and outcomes, a frequent temptation is
to present huge tables with multiple rows and columns. This is a
mistake. These tables can be challenging to sort through, and
the clinical importance of the story resulting from the analysis
can be lost. In our experience, a thoughtful figure often captures
the take-home message in a way that is more interpretable and
memorable to readers than rows of data tables.
You should keep careful track of subjects you decide to
exclude from the analysis and why. Editors, reviewers, and
readers will want to know this information. The best way to keep
track is to construct a flow diagram from the original
denominator to the final sample.
Don’t confuse statistical significance with clinical importance
in large datasets. Due to large sample sizes, associations may be
statistically significant but not clinically meaningful. Be mindful
of what is meaningful from a clinical or policy perspective. One
concern that frequently arises at this stage in large database
research is the acceptability of “exploratory” analyses, or the
practice of examining associations between multiple factors of
interest. On the one hand, exploratory analyses risk finding a
significant association by chance alone from testing multiple
associations (a false-positive result). On the other hand, the
critical issue is not a statistical one, but rather whether the issue
is important.
10 Exploratory analyses are acceptable if done in a
thoughtful way that serves an a priori hypothesis, but not if
merely data dredging looking for associations.
We recommend consulting with a statistician when using
data from a complex survey design (see Table 2)o rd e v e l o p i n ga
conceptually advanced study design, for example, using
longitudinal data, multilevel modeling with clustered data, or
surivival analysis. The value of input (even if informal) from a
927 Smith et al.: Research with Secondary Data JGIMstatistician or other advisor with substantial methodological
expertise cannot be overstated.
CONCLUSIONS
Case Conclusion. Two years after he began the project the
fellow completes the analysis and publishes the paper in a
peer-reviewed journal.
11
A 2-year timeline from inception to publication is typical for
large database research. Academic potential is commonly
assessed by the ability to see a study through to publication in
apeer-reviewedjournal.Thistimelineallowsafellowwhobegana
secondary analysis at the start of a 2-year training program to
search for a job with an article under review or in press.
In conclusion, secondary dataset research has tremendous
advantages, including the ability to assess outcomes that would
be difficult or impossible to study using primary data collection,
such as those involving exceptionally long follow-up times orrare
outcomes. For junior investigators, the potential for a shorter
time to publication may help secure a job or career development
funding. Some of the time “saved” by not collecting data yourself,
however, needs to be “spent” becoming familiar with the dataset
in intimate detail. Ultimately, the same factors that apply to
successful primary data analysis apply to secondary data
analysis, including the development of a clear research
question, study sample, appropriate measures, and a
thoughtful analytic approach.
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